Search

everythinglearnresearchcommunity

for

Search:↓

Liposomal delivery systems improve drug absorption through the skin, offering potential for better treatments.

Platelet-rich plasma helps treat hair loss, and better screening improves transfusion safety.

Overdosing on veterinary albendazole can cause severe health issues like hair loss and low blood cell count.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Different rheumatological diseases can cause specific skin problems.

Testosterone's effects on COVID-19 are unclear and need more research.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Vaccinated healthcare workers rarely experience long COVID-19 symptoms.

Long-COVID symptoms can last more than a year and change over time.

Infectious virus was not found after the third remdesivir dose, suggesting early end of isolation is possible.

Certain alkaloids could help create new coronavirus drugs.

Old age, male sex, smoking, and obesity may affect COVID-19 severity, but more research is needed.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

18% of COVID-19 survivors experience PTSD, with risk factors including age, gender, smoking, and lung damage.

Older males had higher death rates, and Latin Americans were more often in the ICU during the COVID-19 outbreak in a Spanish hospital.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Genetic differences affect COVID-19 severity and treatment development.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

More research is needed to improve telemedicine in primary care.

Older age and existing health issues increase COVID-19 death risk.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.